Your browser doesn't support javascript.
How the COVID-19 pandemic changed cellular therapy at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital.
Tanhehco, Yvette C; Schwartz, Joseph.
  • Tanhehco YC; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
  • Schwartz J; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
Transfusion ; 60(9): 1905-1909, 2020 09.
Article in English | MEDLINE | ID: covidwho-613577
ABSTRACT
New York is at the epicenter of the coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 virus. Columbia University Irving Medical Center/NewYork-Presbyterian Hospital (CUIMC/NYPH) had to make changes to its cellular therapy operations to ensure patient, donor, and staff safety and well-being. In this article, we discuss the process changes we instituted for cellular therapy clinical care, collection, processing, and cryopreservation to cope with the rapidly evolving pandemic.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Academic Medical Centers / Pandemics / Cell- and Tissue-Based Therapy / SARS-CoV-2 / COVID-19 Type of study: Randomized controlled trials Limits: Adult / Child / Humans Country/Region as subject: North America Language: English Journal: Transfusion Year: 2020 Document Type: Article Affiliation country: Trf.15956

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Academic Medical Centers / Pandemics / Cell- and Tissue-Based Therapy / SARS-CoV-2 / COVID-19 Type of study: Randomized controlled trials Limits: Adult / Child / Humans Country/Region as subject: North America Language: English Journal: Transfusion Year: 2020 Document Type: Article Affiliation country: Trf.15956